Mounjaro (tirzepatide) has rapidly become one of the most discussed weight management medications in clinical practice — and for good reason. Its dual mechanism — simultaneously activating both GLP-1 and GIP receptors — produces a degree of weight reduction and metabolic improvement that significantly exceeds what earlier single-agonist medications achieved. The Mounjaro metabolic program in Kolkata at IMAGE Clinic provides structured, medically supervised access to tirzepatide for appropriate candidates — with the metabolic assessment, ongoing monitoring, and nutritional and lifestyle support that determines whether the treatment produces lasting results or just temporary weight loss that reverses when the medication is stopped.
This guide explains what Mounjaro actually is, who is an appropriate candidate for the Mounjaro metabolic program in Kolkata, what the programme at IMAGE Clinic involves, and what realistic expectations look like for patients considering this treatment.
| Interested in the Mounjaro metabolic program in Kolkata? Book your eligibility assessment at IMAGE Clinic. Book Your Mounjaro Assessment at IMAGE Clinic |
What Is Mounjaro (Tirzepatide)?
The Mechanism — Dual GLP-1 and GIP Agonism
Tirzepatide (marketed as Mounjaro) is a weekly injectable medication that activates two incretin hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual agonism is what distinguishes Mounjaro from earlier weight management medications like semaglutide (Ozempic/Wegovy), which act on GLP-1 alone.
GLP-1 agonism produces: reduced appetite and food intake by acting on hypothalamic hunger centres; slowed gastric emptying that extends the feeling of fullness; and improved insulin secretion in response to meals. GIP agonism adds: enhanced insulin sensitivity at the tissue level; a complementary effect on appetite suppression through different neural pathways; and improvement in adipose tissue function that reduces the inflammatory burden of excess fat. Together, these produce greater weight reduction and metabolic improvement than either mechanism alone.
Clinical Efficacy — What the Evidence Shows
In the SURMOUNT-1 trial — the landmark Phase 3 trial for tirzepatide in obesity — patients receiving the highest dose (15mg weekly) achieved a mean weight reduction of 20.9 per cent of body weight over seventy-two weeks. This is the highest weight reduction ever demonstrated for a pharmaceutical agent in a major clinical trial — significantly exceeding what semaglutide and older GLP-1 agonists produced in equivalent populations. The metabolic improvements alongside weight loss — reductions in HbA1c, triglycerides, blood pressure, and inflammatory markers — represent outcomes that reduce cardiovascular and diabetes risk meaningfully.
Who Is an Appropriate Candidate for the Mounjaro Metabolic Program in Kolkata?
Not every patient seeking weight loss is an appropriate candidate for the Mounjaro metabolic program in Kolkata. IMAGE Clinic’s eligibility assessment evaluates the following criteria before prescribing tirzepatide:
- BMI 30+ (or BMI 27.5+ with weight-related comorbidity): The clinical threshold for pharmacological weight management. Weight-related comorbidities that lower the BMI threshold include Type 2 diabetes, hypertension, obstructive sleep apnoea, fatty liver disease, and PCOS. Patients below these thresholds are better served by structured lifestyle programmes rather than pharmacological intervention.
- No contraindications: Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2); patients with a history of pancreatitis; and patients with severe gastroparesis. These are assessed at the initial evaluation.
- Willingness to commit to the full programme: Mounjaro produces weight loss while it is being taken — but that weight loss is not self-sustaining. Patients who stop the medication without having established lifestyle changes that maintain their metabolic health typically regain weight. The programme at IMAGE Clinic requires commitment to the nutritional and lifestyle programme that makes the medication’s effects lasting.
- Realistic expectations: Mounjaro is a powerful tool — not a cure. The most important predictor of long-term success is the lifestyle infrastructure built during the treatment period, not the medication itself.
| Find out if you are an appropriate candidate for the Mounjaro metabolic program in Kolkata. Book your eligibility assessment. Book Your Mounjaro Eligibility Assessment |
What the Mounjaro Metabolic Program in Kolkata at IMAGE Clinic Involves
Step 1: Comprehensive Metabolic Assessment
The metabolic panel testing at IMAGE Clinic before initiating Mounjaro includes: fasting glucose and insulin (HOMA-IR for insulin resistance quantification); HbA1c; full lipid panel; thyroid function; liver function (fatty liver assessment); kidney function; full blood count; and for women of reproductive age, a hormonal panel including testosterone, DHEAS, and LH/FSH. This baseline panel establishes the metabolic status, confirms eligibility, and provides the reference points against which improvement is measured at each monitoring visit.
Step 2: Dose Titration
Tirzepatide is started at 2.5mg weekly and increased in 2.5mg increments every four weeks — up to a maximum of 15mg weekly. This slow titration is essential for managing the gastrointestinal side effects (nausea, occasional vomiting, constipation) that are the most common adverse effects in the early weeks. IMAGE Clinic’s medical team monitors each dose increase and adjusts the titration schedule based on the patient’s tolerance and response.
Important Read: Success Story: How One Kolkata Patient Lost 20kg with Medical Weight Management
Step 3: Nutritional and Lifestyle Programme
Mounjaro reduces appetite significantly — but the nutritional quality of the reduced food intake matters enormously for the outcome. IMAGE Clinic’s medical nutrition integration team works alongside the Mounjaro programme to ensure adequate protein intake (to preserve muscle mass during weight loss), micronutrient sufficiency, and a dietary pattern that supports the insulin sensitisation effects of the medication. The lifestyle programme — structured physical activity, stress management, and sleep optimisation — is equally essential: the metabolic improvements produced by Mounjaro are amplified by concurrent lifestyle change and reduced without it.
Step 4: Regular Monitoring
Patients on the Mounjaro metabolic program in Kolkata at IMAGE Clinic are monitored at four-weekly intervals for the first six months — with weight, metabolic panel repeat, blood pressure, and symptom review at each visit. The monitoring is where the dose adjustments, nutritional corrections, and programme modifications are made. Patients who are monitored consistently achieve significantly better outcomes than those who receive the prescription and are not reviewed regularly. IMAGE Clinic’s anti-ageing medicine programme integrates with the Mounjaro programme for patients whose weight management goals are part of a broader longevity and metabolic health strategy.
Realistic Expectations: What Mounjaro Does and Does Not Do
| Expectation | Realistic | Not Realistic |
| Weight loss amount | 15–22% of body weight over 12–18 months at maximum dose in appropriate candidates | Dramatic results in 4–6 weeks — the dose titration phase produces modest initial loss |
| Speed of results | Meaningful weight loss visible from month 2–3; significant loss by month 6 | Instant or rapid loss — this is a gradual, sustained programme |
| Maintenance without lifestyle change | Medication sustained while active — but regain occurs on stopping without lifestyle change | Permanent weight loss with medication alone, without concurrent lifestyle programme |
| Metabolic improvement | Significant HbA1c reduction, triglyceride improvement, blood pressure reduction | Complete reversal of established diabetes without concurrent lifestyle change |
| Side effects | Nausea in the first 4–8 weeks (managed with slow titration); constipation; reduced appetite | Zero side effects — GI effects are common in the titration phase |
People Also Ask: Mounjaro Metabolic Program in Kolkata
What is the Mounjaro metabolic program in Kolkata?
Short answer: The Mounjaro metabolic program in Kolkata at IMAGE Clinic is a medically supervised weight management programme using tirzepatide (Mounjaro) — a dual GLP-1 and GIP receptor agonist. It includes a comprehensive metabolic assessment before starting, structured dose titration, a parallel medical nutrition programme, and regular four-weekly monitoring. It is designed for appropriate candidates with BMI 30+ (or 27.5+ with comorbidities) who are committed to concurrent lifestyle change.
Who is eligible for the Mounjaro program in Kolkata?
Short answer: Eligible candidates for the Mounjaro metabolic program in Kolkata are those with BMI 30+ (or BMI 27.5+ with weight-related comorbidities such as Type 2 diabetes, hypertension, PCOS, or fatty liver disease) who have no contraindications (personal/family history of medullary thyroid carcinoma, MEN2, or pancreatitis) and who are committed to the concurrent nutritional and lifestyle programme. Eligibility is confirmed at the initial metabolic assessment.
How much weight can I lose on Mounjaro?
Short answer: In clinical trials, patients on the highest dose of tirzepatide achieved a mean weight loss of approximately 20–21 per cent of body weight over seventy-two weeks — significantly more than any previous weight management medication. In real-world practice through the Mounjaro metabolic program in Kolkata, outcomes vary based on starting BMI, metabolic status, adherence to the nutritional programme, and dose achieved. An individualised expectation is set at the initial assessment.
What are the side effects of Mounjaro?
Short answer: The most common side effects of Mounjaro are gastrointestinal — nausea, occasional vomiting, constipation, and reduced appetite — most pronounced during the dose titration phase (the first eight to twelve weeks). These are managed by starting at the lowest dose and increasing slowly. IMAGE Clinic’s Mounjaro programme includes dietary guidance specifically designed to minimise GI side effects during titration. Serious side effects are rare when eligibility criteria are properly assessed.
What happens when I stop taking Mounjaro?
Short answer: Tirzepatide suppresses appetite and improves insulin sensitivity while it is being taken. On stopping the medication, these pharmacological effects reverse — and without concurrent lifestyle changes embedded during the treatment period, weight regain occurs in most patients. The Mounjaro metabolic program in Kolkata at IMAGE Clinic is specifically designed to build the nutritional habits, metabolic health, and lifestyle infrastructure that determine whether the weight lost during treatment is maintained after the medication is tapered.
| Mounjaro Metabolic Program in Kolkata — IMAGE Clinic Clinically supervised. Evidence-based. Lasting metabolic results. Book Your Appointment Now | Call: 09830 836 666 Or visit your nearest IMAGE Clinic — find your nearest branch here. |
